Myocarditis Up After Second Dose of mRNA-1273 Versus BNT162b2

WEDNESDAY, Nov. 9, 2022 -- The rates of myocarditis and pericarditis are increased after receipt of the second dose of mRNA-1273 versus BNT162b2, according to a study published in the Nov. 15 issue of the Journal of the American College of...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news